Natco Pharma's Q2 consolidated profit fell 61% to Rs 203 crore as revenue dropped about 29%.
Results · 13 Nov 2026 · Natco Pharma (NATCOPHARM)
| Latest quarter | ₹ Cr |
|---|---|
| Operating profit | 258 |
| Net profit | 203 |
Lower sales of generic Lenalidomide, a cancer drug, drove the fall, and EBITDA dropped 55% to Rs 258 crore.
Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.